市場調查報告書

植物性醫藥品、植物來源醫藥品的全球市場:各原料、劑型、治療領域、地區的預測(2019年∼2026年)

Global Botanical and Plant-derived Drugs Market Size Study, by Source by Dosage Form by Therapeutic Applications and Regional Forecasts 2019-2026

出版商 Bizwit Research & Consulting LLP 商品編碼 920272
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
植物性醫藥品、植物來源醫藥品的全球市場:各原料、劑型、治療領域、地區的預測(2019年∼2026年) Global Botanical and Plant-derived Drugs Market Size Study, by Source by Dosage Form by Therapeutic Applications and Regional Forecasts 2019-2026
出版日期: 2019年12月15日內容資訊: 英文
簡介

全球植物性醫藥品、植物來源醫藥品市場在2018年估算為約312億美元,在2019年∼2026年的預測期間內,預計將以6.10%以上健全的成長率發展。植物性醫藥品、植物來源醫藥品,有助於對中樞神經系統障礙,感染疾病,心血管疾病,呼吸疾病等的各種疾病的治療。這些藥物,作為同類療法和阿育吠陀藥等醫學和治療重要的組件使用。腸胃不順,過敏反應等合成藥的消費造成的副作用的風險增加,使植物性醫藥品、植物來源醫藥品的需求增加。再加上慢性疾病的發生率增加,更加推動市場成長。呼吸系統及感染疾病的治療中的植物性醫藥品、植物來源醫藥品的使用增加,預計在預測期間帶給市場很大的成長機會。譬如,豆植物抽取物,用於心血管疾病的治療。北美,由於植物性醫藥品的普及和高度的技術進步,在市場佔有率方面成為全球主要/重要的地區。亞太地區在2019年∼2024年的預測期間將展現最高的成長率/年複合成長率。植物性醫藥品、植物來源醫藥品的認知度高漲,慢性疾病的盛行率增加等,預計帶給亞太地區的植物性醫藥品、植物來源醫藥品市場成長機會。

本報告提供全球植物性醫藥品、植物來源醫藥品市場調查,市場概要,各原料類型、劑型、治療領域、地區的市場規模的變化與預測,市場成長要素及課題分析,成本結構,市場機會,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 摘要整理

  • 市場概述
  • 整體及各市場區隔的市場預測
    • 植物性醫藥品、植物來源醫藥品市場:各地區
    • 植物性醫藥品、植物來源醫藥品市場:各原料
    • 植物性醫藥品、植物來源醫藥品市場:各劑型
    • 植物性醫藥品、植物來源醫藥品市場:各治療用途
  • 主要的趨勢
  • 估計方法
  • 調查的前提條件

第2章 全球性植物性醫藥品、植物來源醫藥品的市場定義和範圍

  • 調查的目的
  • 市場定義和範圍
    • 調查範圍
    • 產業的演進
  • 研究考慮年份
  • 貨幣換算比率

第3章 全球植物性醫藥品、植物來源醫藥品的市場動態

  • 植物性醫藥品、植物來源醫藥品的市場影響分析
    • 市場成長要素
    • 市場課題
    • 市場機會

第4章 產業分析

  • 五力分析模型
    • 供應商談判力
    • 買主談判力
    • 新加入廠商的威脅
    • 替代品的威脅
    • 競爭對手
    • 對五力分析模型的未來方法
  • PEST分析
    • 政治
    • 經濟
    • 社會
    • 技術性
  • 投資採用模式
  • 分析師的推薦和結論

第5章 全球植物性醫藥品、植物來源醫藥品市場:各原料

  • 市場概述
  • 全球植物性醫藥品、植物來源醫藥品市場效能 - 潛力分析:各原料
  • 全球植物性醫藥品、植物來源醫藥品市場預測:各原料
  • 植物性醫藥品、植物來源醫藥品市場:子區隔分析
    • 植物
    • 藻類
    • 大型菌類

第6章 全球植物性醫藥品、植物來源醫藥品市場:各劑型

  • 市場概述
  • 全球植物性醫藥品、植物來源醫藥品市場效能 - 潛力分析:各劑型
  • 全球植物性醫藥品、植物來源醫藥品市場預測:各劑型
  • 植物性醫藥品、植物來源醫藥品市場:子區隔分析
    • 丸藥
    • 錠劑
    • 膠囊劑
    • 注射劑

第7章 全球植物性醫藥品、植物來源醫藥品市場:各治療領域

  • 市場概述
  • 全球植物性醫藥品、植物來源醫藥品市場效能 - 潛力分析:各治療用途
  • 全球植物性醫藥品、植物來源醫藥品市場預測:各治療用途
  • 植物性醫藥品、植物來源醫藥品市場:子區隔分析
    • 中樞神經系統
    • 心血管疾病
    • 感染疾病
    • 呼吸疾病

第8章 全球植物性醫藥品、植物來源醫藥品市場:地區分析

  • 植物性醫藥品、植物來源醫藥品市場:地區市場概述
  • 北美的植物性醫藥品、植物來源醫藥品市場
    • 美國的植物性醫藥品、植物來源醫藥品市場
    • 加拿大的植物性醫藥品、植物來源醫藥品市場
  • 歐洲的植物性醫藥品、植物來源醫藥品市場概述
    • 英國的植物性醫藥品、植物來源醫藥品市場
    • 歐洲的其他地區的植物性醫藥品、植物來源醫藥品市場
  • 亞太地區的植物性醫藥品、植物來源醫藥品市場概述
    • 中國的植物性醫藥品、植物來源醫藥品市場
    • 印度的植物性醫藥品、植物來源醫藥品市場
    • 日本的植物性醫藥品、植物來源醫藥品的市場
    • 亞太地區的植物性醫藥品、植物來源醫藥品市場
  • 南美的植物性醫藥品、植物來源醫藥品市場概述
    • 巴西的植物性醫藥品、植物來源醫藥品市場
    • 墨西哥的植物性醫藥品、植物來源醫藥品市場
  • 其他地區的植物性醫藥品、植物來源醫藥品市場

第9章 競爭情形

  • 最高市場策略
  • 公司概要
    • Bayer Healthcare LLC
    • Abott Laboratories
    • GlaxoSmithKline plc
    • Pfizer Inc, Sanofi
    • Actelion Pharmaceuticals Ltd
    • Aimil Pharmaceuticals India Ltd
    • Boehringer Ingelheim GmbH
    • Bristol-Myers Squibb Company
    • Concordia Pharmaceuticals Inc.
    • GW Pharmaceuticals plc

第10章 調查方法

  • 調查方法
    • 資料探勘
    • 分析
    • 市場預測
    • 檢驗
    • 出版
  • 研究屬性
  • 調查的前提條件
目錄

Global Botanical and plant-derived drugs market is valued approximately at USD 31.2 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 6.10% over the forecast period 2019-2026. Botanical drugs are derived from medicinal plants. Botanical drugs contain algae vegetable substance, and macroscopic fungi. Botanical and plant derived drugs help in treatment of various diseases, such as central nervous system disorders, infectious diseases cardiovascular diseases, and respiratory diseases. These drugs are used as an important component in medicine and therapies such as homeopathy and ayurvedic medicines. Increasing risk of side effects with the consumption of synthetic drugs such as gastrointestinal upsets, allergic reactions and more, these factors are increasing the demand for botanical and plant derived drugs. In addition, increasing incidences of chronic diseases are further contributing towards market growth. Increasing adoption of botanical and plant derived drugs in the treatment of respiratory and infectious disease is expected to create significant growth opportunity in the market over the forecast period. For instance, convallaria majalis plant extract is used in for the treatment of cardiovascular disease. Mytesi is a botanical drug approved for the symptom's relief on noninfectious diarrhea in adults with HIV/AIDS. Also, introduction of medicines made from plants for the treatment of cardiac such as acetyldigoxin, adoniside are also rising adoption of botanical and plant derived drugs. However, stringent laws and regulations for approval of botanical drugs impedes the growth of the market over the forecast period of 2019-2026.

The regional analysis of global Botanical and plant-derived drugs market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the high adoption of herbal drugs and technological advances. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as increasing awareness towards botanical and plant derived drugs and increasing prevalence of chronic diseases would create lucrative growth prospects for the Botanical and plant-derived drugs market across Asia-Pacific region.

Major market player included in this report are:

Bayer Healthcare LLC

Abott Laboratories

GlaxoSmithKline plc

Pfizer Inc, Sanofi

Actelion Pharmaceuticals Ltd

Aimil Pharmaceuticals India Ltd

Boehringer Ingelheim GmbH

Bristol-Myers Squibb Company

Concordia Pharmaceuticals Inc.

GW Pharmaceuticals plc

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By source:

Plant

Algae

Macroscopic fungi

By dosage form:

Pills

Tablets

Capsules

Injection

By Therapeutic applications:

Central Nervous System

Cardiovascular Diseases

Infectious Diseases

Respiratory Diseases

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2016, 2017

Base year - 2018

Forecast period - 2019 to 2026

Target Audience of the Global Botanical and plant-derived drugs Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
    • 1.2.1. Botanical and plant-derived drugs Market, by Region, 2017-2026 (USD Billion)
    • 1.2.2. Botanical and plant-derived drugs Market, by source, 2017-2026 (USD Billion)
    • 1.2.3. Botanical and plant-derived drugs Market, by dosage form, 2017-2026 (USD Billion)
    • 1.2.4. Botanical and plant-derived drugs Market, by Therapeutic application, 2017-2026 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Botanical and plant-derived drugs Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Botanical and plant-derived drugs Market Dynamics

  • 3.1. Botanical and plant-derived drugs Market Impact Analysis (2018-2026)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Botanical and plant-derived drugs Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2016-2026)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Botanical and plant-derived drugs Market, by source

  • 5.1. Market Snapshot
  • 5.2. Global Botanical and plant-derived drugs Market by source, Performance - Potential Analysis
  • 5.3. Global Botanical and plant-derived drugs Market Estimates & Forecasts by By source 2016-2026 (USD Billion)
  • 5.4. Botanical and plant-derived drugs Market, Sub Segment Analysis
    • 5.4.1. Plant
    • 5.4.2. Algae
    • 5.4.3. Macroscopic fungi

Chapter 6. Global Botanical and plant-derived drugs Market, by dosage form

  • 6.1. Market Snapshot
  • 6.2. Global Botanical and plant-derived drugs Market by dosage form, Performance - Potential Analysis
  • 6.3. Global Botanical and plant-derived drugs Market Estimates & Forecasts by dosage form 2016-2026 (USD Billion)
  • 6.4. Botanical and plant-derived drugs Market, Sub Segment Analysis
    • 6.4.1. Pills
    • 6.4.2. Tablets
    • 6.4.3. Capsules
    • 6.4.4. Injection

Chapter 7. Global Botanical and plant-derived drugs Market, by Therapeutic applications

  • 7.1. Market Snapshot
  • 7.2. Global Botanical and plant-derived drugs Market by therapeutic application, Performance - Potential Analysis
  • 7.3. Global Botanical and plant-derived drugs Market Estimates & Forecasts by dosage form 2016-2026 (USD Billion)
  • 7.4. Botanical and plant-derived drugs Market, Sub Segment Analysis
    • 7.4.1. Central Nervous System
    • 7.4.2. Cardiovascular Diseases
    • 7.4.3. Infectious Diseases
    • 7.4.4. Respiratory Diseases

Chapter 8. Global Botanical and plant-derived drugs Market, Regional Analysis

  • 8.1. Botanical and plant-derived drugs Market, Regional Market Snapshot
  • 8.2. North America Botanical and plant-derived drugs Market
    • 8.2.1. U.S. Botanical and plant-derived drugs Market
      • 8.2.1.1. Source breakdown estimates & forecasts, 2016-2026
      • 8.2.1.2. Dosage form breakdown estimates & forecasts, 2016-2026
      • 8.2.1.3. Therapeutic application breakdown estimates & forecasts, 2016-2026
    • 8.2.2. Canada Botanical and plant-derived drugs Market
  • 8.3. Europe Botanical and plant-derived drugs Market Snapshot
    • 8.3.1. U.K. Botanical and plant-derived drugs Market
    • 8.3.2. Rest of Europe Botanical and plant-derived drugs Market
  • 8.4. Asia-Pacific Botanical and plant-derived drugs Market Snapshot
    • 8.4.1. China Botanical and plant-derived drugs Market
    • 8.4.2. India Botanical and plant-derived drugs Market
    • 8.4.3. Japan Botanical and plant-derived drugs Market
    • 8.4.4. Rest of Asia Pacific Botanical and plant-derived drugs Market
  • 8.5. Latin America Botanical and plant-derived drugs Market Snapshot
    • 8.5.1. Brazil Botanical and plant-derived drugs Market
    • 8.5.2. Mexico Botanical and plant-derived drugs Market
  • 8.6. Rest of The World Botanical and plant-derived drugs Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Bayer Healthcare LLC
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Abott Laboratories
    • 9.2.3. GlaxoSmithKline plc
    • 9.2.4. Pfizer Inc, Sanofi
    • 9.2.5. Actelion Pharmaceuticals Ltd
    • 9.2.6. Aimil Pharmaceuticals India Ltd
    • 9.2.7. Boehringer Ingelheim GmbH
    • 9.2.8. Bristol-Myers Squibb Company
    • 9.2.9. Concordia Pharmaceuticals Inc.
    • 9.2.10. GW Pharmaceuticals plc

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET
  • TABLE 3. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
  • TABLE 7. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY BY SOURCE 2016-2026 (USD BILLION)
  • TABLE 8. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY DOSAGE FORM 2016-2026 (USD BILLION)
  • TABLE 9. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 10. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 11. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 12. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 13. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 14. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 15. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 16. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 17. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 18. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 19. U.S. BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 20. U.S. BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 21. U.S. BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 22. CANADA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 23. CANADA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 24. CANADA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 25. UK BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 26. UK BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 27. UK BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 28. GERMANY BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 29. GERMANY BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 30. GERMANY BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 31. ROE BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 32. ROE BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 33. ROE BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 34. CHINA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 35. CHINA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 36. CHINA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 37. INDIA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 38. INDIA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 39. INDIA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 40. JAPAN BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 41. JAPAN BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 42. JAPAN BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 43. ROAPAC BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 44. ROAPAC BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 45. ROAPAC BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 46. BRAZIL BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 47. BRAZIL BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 48. BRAZIL BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 49. MEXICO BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 50. MEXICO BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 51. MEXICO BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 52. ROLA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 53. ROLA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 54. ROLA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 55. ROW BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 56. ROW BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 57. ROW BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

List of Figures

  • FIG 1. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, RESEARCH METHODOLOGY
  • FIG 2. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, KEY TRENDS 2018
  • FIG 5. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, GROWTH PROSPECTS 2019-2026
  • FIG 6. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, PEST ANALYSIS
  • FIG 8. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 10. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 11. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 12. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 13. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 14. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, REGIONAL SNAPSHOT 2016 & 2026
  • FIG 15. NORTH AMERICA BOTANICAL AND PLANT-DERIVED DRUGS MARKET 2016 & 2026 (USD BILLION)
  • FIG 16. EUROPE BOTANICAL AND PLANT-DERIVED DRUGS MARKET 2016 & 2026 (USD BILLION)
  • FIG 17. ASIA PACIFIC BOTANICAL AND PLANT-DERIVED DRUGS MARKET 2016 & 2026 (USD BILLION)
  • FIG 18. LATIN AMERICA BOTANICAL AND PLANT-DERIVED DRUGS MARKET 2016 & 2026 (USD BILLION)
  • FIG 19. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, COMPANY MARKET SHARE ANALYSIS (2018)